Skip to main content

Biotech upsizes target for pending IPO to $250M

Bicara Therapeutics is expected to go public this week.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.